{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:08:06Z","timestamp":1784171286745,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T00:00:00Z","timestamp":1375660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.cca.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T13:01:42Z","timestamp":1369918902000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens"],"prefix":"10.1016","volume":"424","author":[{"given":"Chelsea","family":"Bentow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Infantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Benucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Lakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.05.011_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-6632.2009.05127.x","article-title":"Epitope specificity and significance in systemic autoimmune diseases","volume":"1183","author":"Mahler","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2013.05.011_bb0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2010.06.005","article-title":"Anti-Scl-70 (topo-I) antibodies in SLE: myth or reality?","volume":"9","author":"Mahler","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2013.05.011_bb0015","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/ar1455","article-title":"Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies","volume":"7","author":"Mahler","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2013.05.011_bb0020","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2013.05.011_bb0025","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","volume":"14","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2013.05.011_bb0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study","volume":"10","author":"Ghillani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2013.05.011_bb0035","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.05.011_bb0040","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2013.05.011_bb0045","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1191\/0961203303lu439oa","article-title":"Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system","volume":"12","author":"Lopez-Longo","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.cca.2013.05.011_bb0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1191\/0961203306lu2327oa","article-title":"Advances and applications of multiplexed diagnostic technologies in autoimmune diseases","volume":"15","author":"Fritzler","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.cca.2013.05.011_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08916930400022707","article-title":"Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases","volume":"38","author":"Shovman","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cca.2013.05.011_bb0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1196\/annals.1313.120","article-title":"Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural\/predictive autoantibodies","volume":"1050","author":"Shovman","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2013.05.011_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jim.2010.04.005","article-title":"Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus","volume":"358","author":"Hanly","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cca.2013.05.011_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nm0302-295","article-title":"Autoantigen microarrays for multiplex characterization of autoantibody responses","volume":"8","author":"Robinson","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2013.05.011_bb0075","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cca.2012.01.004","article-title":"Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies","volume":"413","author":"Mahler","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.05.011_bb0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/jaut.1998.0265","article-title":"The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies","volume":"12","author":"Frank","year":"1999","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cca.2013.05.011_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/cclm-2012-0191","article-title":"Current state of diagnostic technologies in the autoimmunology laboratory","volume":"51","author":"Tozzoli","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2013.05.011_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1568-9972(01)00013-1","article-title":"Recombinant autoantigens","volume":"1","author":"Schmitt","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2013.05.011_bb0095","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1309\/AJCPX1SQXKI3MWNN","article-title":"Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases","volume":"138","author":"Pi","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cca.2013.05.011_bb0100","doi-asserted-by":"crossref","first-page":"494356","DOI":"10.1155\/2012\/494356","article-title":"The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases","volume":"2012","author":"Mahler","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.cca.2013.05.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-012-2141-y","article-title":"An evaluation of autoimmune antibody testing patterns in a Canadian health region and an evaluation of a laboratory algorithm aimed at reducing unnecessary testing","author":"Man","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2013.05.011_bb0110","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2013.05.011_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","article-title":"Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease","volume":"9","author":"Fauchais","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2013.05.011_bb0120","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/clinchem\/48.12.2171","article-title":"Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests","volume":"48","author":"Hoffman","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.05.011_bb0125","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar2548","article-title":"Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodies","volume":"10","author":"Mahler","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2013.05.011_bb0130","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1373\/clinchem.2004.035964","article-title":"Detection of anti-SSA antibodies by indirect immunofluorescence","volume":"50","author":"Bossuyt","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.05.011_bb0135","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u201chealthy\u201d individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2013.05.011_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/CDLI.4.2.185-188.1997","article-title":"Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay","volume":"4","author":"Gniewek","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cca.2013.05.011_bb0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CVI.00034-07","article-title":"Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens","volume":"14","author":"Avaniss-Aghajani","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.cca.2013.05.011_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-198103000-00002","article-title":"Serological findings in patients with \u201cANA-negative\u201d systemic lupus erythematosus","volume":"60","author":"Maddison","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2013.05.011_bb0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1191\/096120300678828091","article-title":"ANA negative systemic lupus erythematosus sera revisited serologically","volume":"9","author":"Reichlin","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.cca.2013.05.011_bb0160","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.md.0000173181.87969.eb","article-title":"Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases","volume":"84","author":"Davis","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2013.05.011_bb0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jaut.2003.12.004","article-title":"Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy","volume":"22","author":"Dahle","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cca.2013.05.011_bb0170","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2174\/092986706778201639","article-title":"The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases","volume":"13","author":"Fritzler","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.cca.2013.05.011_bb0175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jcla.21522","article-title":"Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease","volume":"26","author":"Lee","year":"2012","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.cca.2013.05.011_bb0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jim.2009.10.003","article-title":"Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus","volume":"352","author":"Hanly","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cca.2013.05.011_bb0185","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00296-006-0271-8","article-title":"Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results","volume":"27","author":"Caramaschi","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2013.05.011_bb0190","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1196\/annals.1398.052","article-title":"Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera","volume":"1109","author":"Copple","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2013.05.011_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10446670410001670490","article-title":"Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation\u2014a homogeneous, multiplexed system","volume":"11","author":"Gilburd","year":"2004","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.cca.2013.05.011_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2012.02.013","article-title":"Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis","volume":"12","author":"Op De Beeck","year":"2012","journal-title":"Autoimmun Rev"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T05:31:53Z","timestamp":1595827913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113002155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":40,"alternative-id":["S0009898113002155"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.05.011","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}